Attenuated Neural Processing of Risk in Young Adults at Risk for Stimulant Dependence by Reske, Martina et al.
City University of New York (CUNY)
CUNY Academic Works
Publications and Research Queens College
June 2015
Attenuated Neural Processing of Risk in Young
Adults at Risk for Stimulant Dependence
Martina Reske
University of California San Diego
Jennifer L. Stewart
CUNY Queens College
Taru M. Flagan
University of California San Diego
Martin P. Paulus
University of California San Diego
How does access to this work benefit you? Let us know!
Follow this and additional works at: http://academicworks.cuny.edu/qc_pubs
This Article is brought to you for free and open access by the Queens College at CUNY Academic Works. It has been accepted for inclusion in
Publications and Research by an authorized administrator of CUNY Academic Works. For more information, please contact
AcademicWorks@cuny.edu.
Recommended Citation
Reske, M., Stewart, J. L., Flagan, T. M. & Paulus, M. P. (2015). Attenuated Neural Processing of Risk in Young Adults at Risk for
Stimulant Dependence. PLoS ONE, 10(6), e0127010. doi:10.1371/journal.pone.0127010.
RESEARCH ARTICLE
Attenuated Neural Processing of Risk in
Young Adults at Risk for Stimulant
Dependence
Martina Reske1,2,3, Jennifer L. Stewart1,4, Taru M. Flagan1,5, Martin P. Paulus1,6,7*
1 Department of Psychiatry, University of California San Diego, La Jolla, California, United States of
America, 2 Institute of Neuroscience and Medicine (INM-6), Computational and Systems Neuroscience and
Institute for Advanced Simulation (IAS-6), Theoretical Neuroscience, Forschungszentrum Jülich GmbH,
Jülich, Germany, 3 JARA BRAIN Institute I, Jülich, Germany, 4 CUNYQueens College, Queens, New York,
United States of America, 5 University of Texas, Austin, Texas, United States of America, 6 Psychiatry
Service, VA San Diego Healthcare System, La Jolla, California, United States of America, 7 Laureate
Institute for Brain Research, 6655 S Yale Ave, Tulsa, Oklahoma, United States of America
* mpaulus@laureateinstitute.org
Abstract
Objective
Approximately 10% of young adults report non-medical use of stimulants (cocaine, amphet-
amine, methylphenidate), which puts them at risk for the development of dependence. This
fMRI study investigates whether subjects at early stages of stimulant use show altered deci-
sion making processing.
Methods
158 occasional stimulants users (OSU) and 50 comparison subjects (CS) performed a
“risky gains” decision making task during which they could select safe options (cash in 20
cents) or gamble them for double or nothing in two consecutive gambles (win or lose 40 or
80 cents, “risky decisions”). The primary analysis focused on risky versus safe decisions.
Three secondary analyses were conducted: First, a robust regression examined the effect
of lifetime exposure to stimulants and marijuana; second, subgroups of OSU with >1000
(n = 42), or <50 lifetime marijuana uses (n = 32), were compared to CS with <50 lifetime
uses (n = 46) to examine potential marijuana effects; third, brain activation associated with
behavioral adjustment following monetary losses was probed.
Results
There were no behavioral differences between groups. OSU showed attenuated activation
across risky and safe decisions in prefrontal cortex, insula, and dorsal striatum, exhibited
lower anterior cingulate cortex (ACC) and dorsal striatum activation for risky decisions and
greater inferior frontal gyrus activation for safe decisions. Those OSU with relatively more
stimulant use showed greater dorsal ACC and posterior insula attenuation. In comparison,
greater lifetime marijuana use was associated with less neural differentiation between risky
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and safe decisions. OSU who chose more safe responses after losses exhibited similarities
with CS relative to those preferring risky options.
Discussion
Individuals at risk for the development of stimulant use disorders presented less differentiat-
ed neural processing of risky and safe options. Specifically, OSU show attenuated brain re-
sponse in regions critical for performance monitoring, reward processing and interoceptive
awareness. Marijuana had additive effects by diminishing neural risk differentiation.
Introduction
The use of cocaine, prescription amphetamines and methylphenidate (which are referred to as
“stimulants”) for non-medical purposes by young adults to enhance performance in academic
and/or social situations poses an increasing public health problem [1]. For example, up to 16%
of individuals experimenting with cocaine develop dependence within 10 years [2]. Exposure
to drugs of abuse particularly during brain maturation in adolescence and young adulthood in-
creases the risk of future dependence [3]. Exposed to highly competitive social and academic
situations, 7–8% of U.S. [4, 5] and 20% of German [6] college students report the off-prescrip-
tion use of cognitive enhancers, for example of stimulants, in the past year. Up to 17% of male
and 11% of female undergraduates admit lifetime use of prescription stimulants [6, 7].
Despite this growing trend, few studies have examined biological and behavioral processes
that might distinguish individuals who use these drugs versus those who do not, providing in-
sights into precursors of stimulant dependence. In particular, previous research typically com-
pared stimulant dependent individuals with non-using healthy subjects. Such study designs,
however, make it impossible to differentiate a predisposing vulnerability reflected in behavioral
performance or neural activation patterns from effects of repeated exposure to neurotoxic sub-
stances and may have misattributed results as a consequence of cumulative use. Longitudinal
study designs starting with adolescents prior to any substance use would be ideal, but these re-
quire an enormous effort and resources. Characterizing phenotypes indicative of a heightened
risk for stimulant dependence by investigating users at very early stages of use on the other
hand allows for the identification of potential precursors of substance related problems. There-
fore, the present study investigates brain activation and behavioral performance in a substan-
tive sample of young occasional stimulant use (OSU) with very limited use. The identification
in brain and behavioral differences in such OSU could suggest that these presumably preceded
the use of stimulants as cumulative neurotoxic exposure is limited.
As a growing literature implicates impaired decision making in stimulant dependent indi-
viduals in high-risk situations [8], this investigation examined whether deficits in decision
making extend to OSU. Risk taking involves selecting an action associated with an uncertain
payoff, the possibility of a beneficial outcome at the potential cost of an adverse outcome [9–
11] wherein individuals need to establish a balance between obtaining rewards and avoiding
losses [12–14]. An important variant is decision making under ambiguity, where outcomes are
unknown or have unknown probability distributions (see e.g. [15]). Learning from outcomes,
particularly from punishment, is pivotal and relies on the ability to respond to changing con-
tingencies by inhibiting a dominant response, and monitoring responses and outcomes. Re-
search shows that individuals with cocaine abuse or dependence exhibit similar risky behavior
in presence of high or low penalties, whereas healthy individuals choose less risky options in
Risk Processing in Occasional Stimulant Users
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the face of high punishment [16]. Moreover, individuals with cocaine, methamphetamine or
marijuana abuse and/or dependence choose greater numbers of risky options than comparison
subjects, particularly on tasks requiring the evaluation of the magnitude and timing of rewards
and punishments [17–22]. Although prior work demonstrates that, like stimulant dependent
individuals, OSU exhibit increased risk-taking behavior but successful behavioral adjustment
after punishment [23], no studies have simultaneously examined brain and behavior perfor-
mance during risky decision making in a large sample of OSU. Hence, the present study exam-
ined neural and behavioral indices in OSU and stimulant naïve comparison subjects (CS)
during a “risky gains” decision making paradigm [23–25].
Main foci for imaging analyses were prefrontal cortices including dorsolateral prefrontal
cortex (DLPFC), superior (SFG) and inferior frontal gyri (IFG), medial frontal cortex (includ-
ing the anterior cingulate cortex, ACC) as well as insula and caudate. In CS, prefrontal recruit-
ment during voluntary risk taking is thought to reflect maintaining task objectives in short
term memory, discerning reward value of available choices, and avoidance of punishment by
inhibiting risky decisions [26, 27], while risk-related involvement of insula and ACC have been
associated with calculation of risk prediction error, as well as the difference between expected
versus actual risk computed when reward probabilities are uncertain [24, 28–31]. Specifically,
dorsal ACC (dACC) activation relates to tonic aspects of cognitive control and goal-oriented
behavior during decision making. It raises with increasing risk and recruits prefrontal brain re-
gions to avoid further risk [32]. Subgenual (sgACC) and rostral ACC (rACC) play essential
roles in hedonic evaluations and motivational aspects of decision making [32–34]. The caudate,
a component of the dorsal striatum, has been linked to motivational and learning-related as-
pects of goal-directed actions [35]. Its role in decision making is based on dopamine-mediated
reinforcement processes and comprises choice-outcome contingency learning via feedback, a
mechanism reinforcing behaviors with positive outcomes and avoiding choices associated with
losses, linking risky decisions with positive and negative outcomes. Lastly, insula activation
during decision making has been conceptualized to reflect a bodily representation of risk as in-
teroceptive signals reach the posterior insula to travel to the anterior insula to generate intero-
ceptive awareness [36, 37].
Given that research in stimulant dependent subjects has indicated hypoactivations com-
pared to non-using comparison subjects in these brain areas [19, 38–47] the present study
sought to determine whether neural activation patterns described in stimulant dependent indi-
viduals extend to OSU. Following primary analyses focusing on overall and risk-specific behav-
ioral and neural decision making differences between OSU and CS, three secondary analyses
were carried out. First, we investigated whether cumulative stimulant use moderated results in
this cross-sectional study within OSU. Respective findings will explicate whether differences in
brain function develop with cumulative neurotoxic exposure or precede stimulant initiation.
Second, we examined whether comorbid THC use affected our findings by means of split
group analyses as OSU frequently use cannabis (Δ9 tetrahydrocannabinol, THC). College stu-
dents reporting the abuse of prescription stimulants, for example, are 10 times as likely to re-
port THC use than students not using stimulants [4]). Third, we quantified risk adjustment-
related brain activation as a measure of learning from outcomes.
Four specific hypotheses were tested. First, consistent with studies of stimulant dependence,
we hypothesized that OSU would exhibit lower DLPFC and SFG activation than CS while navi-
gating risky and safe decisions. Second, based on literature examining decision making in stim-
ulant addiction, we predicted that OSU would demonstrate lower ACC, IFG, insula, and
striatal activation than CS during risky choices. Third, for the analysis focusing on the response
to punishment, we predicted that those OSU who adjust performance after monetary loss to-
wards safe responses would show stronger activation in areas associated with response
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selection and action monitoring (e.g. dACC [19, 38, 40]). Fourth, we anticipated that OSU
would make a larger number of risky behavioral selections than CS [23]. Moreover, we ex-
pected that higher co-use of THC would be associated with more pronounced neurobehavioral
impairments as previous work revealed dose-response effects for higher cognitive functions
that require the integration of multiple cognitive abilities [18]. The prefrontal cortex poses a
main target in that regard.
Methods
Subjects
The University of California San Diego (UCSD) Human Subjects Review Board approved the
study protocol. OSU and stimulant naïve CS were recruited via flyers mailed to>7000 students
at local universities, internet ads (e.g. Craigslist), and local university newspapers. Individuals
were informed that this study aimed to examine behavior and brain functioning of people who
use stimulants. To rule out an active high on stimulants, subjects were instructed to refrain from
illegal substance use72 hours before testing. Subjects gave written informed consent.
OSU were defined as having (1) at least n = 2 off-prescription uses of cocaine or prescription
stimulants (prescription amphetamines, methylphenidate) over the past six months; (2) no evi-
dence for lifetime stimulant dependence; (3) no lifetime use of methylphenidate or prescription
amphetamines for medical reasons; (4) absence of treatment of substance or alcohol-related
problems. The following exclusion criteria were applied for all subjects: (1) current (and past
6 months) diagnosis of major depressive disorder and anxiety disorders; (2) lifetime bipolar
disorder and schizophrenia; (3) antisocial personality disorder and conduct disorder; (4) atten-
tion-deficit hyperactivity disorder (ADHD), (5) current positive urine toxicology test (excep-
tion due to long detectability: THC), (6) lifetime use of ecstasy>25 and (7) head injuries or
loss of consciousness for>5min. Minimal methamphetamine use was not an exclusion criteri-
on in OSU. Fifteen OSU endorsed a mean of n = 4.95 (mean, SD = 44.54) lifetime metham-
phetamine uses, with 11 of these OSU reporting fewer than n = 10 lifetime uses. Additional
inclusion criteria for CS were no lifetime use of stimulants and no lifetime history of substance
or alcohol related problems. Given frequently reported co-use of THC in stimulant users [4],
lifetime THC use did not serve as an exclusion criterion in OSU. To allow for comparability
with OSU, THC use was not an exclusion criterion for CS.
Out of 1214 individuals who participated in phone screens, 231 OSU and 63 CS completed
an in-person clinical interview session. Experienced interviewers administered the Semi Struc-
tured Assessment for the Genetics of Alcoholism [48] and a detailed assessment of lifetime sub-
stance use using Timeline Follow-Back Methods [49]. 158 OSU (61 females, 97 males) and 50
CS (28 females, 22 males) met inclusion criteria and comprised the final sample. Participants’
diagnoses were confirmed in consensus meetings with a board-certified psychiatrist (M.P.P.)
and trained study personnel. Groups did not differ on age or education (t-tests, p’s> 0.61, see
Table 1) while relatively more female CS participated in the study. OSU reported to have initi-
ated stimulant use at the age of 18.39±1.69 (m±SD) years. A total of 64 OSU and 3 CS reported
minimal regular nicotine use. On average, OSU smoked a total of 6.55±4.89 cigarettes per day.
All but three OSU and nineteen CS admitted lifetime THC use. OSU reported more alcohol
use than CS. Scan day urine toxicology was available for 145 OSU and 48 CS and was THC-
positive for 58 OSU and 1 CS. In OSU, number of lifetime stimulant uses correlated with life-
time THC use (r = 0.32, p<0.001) and THC use onset preceded initiation of stimulant use by
2.47±1.98 years (r = 0.39, p<0.001). In addition, 45 OSU met criteria for THC dependence
(47% of these current dependence), whereas 47 OSU and 3 CS met criteria for lifetime THC
abuse. OSU reported higher sensation seeking and impulsivity traits than CS. See Table 1 for
Risk Processing in Occasional Stimulant Users
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sample characteristics and S1 Table for detailed self-reports on impulsivity and sensation
seeking.
Table 1. Sample characteristics by group status.
OSU
n = 158
CS,
n = 50
t-test
results*
Low THC
OSU, n = 32
High THC
OSU, n = 42
CS,
n = 46
One-way ANOVA results*,
Direction THC Subgroups
m (SD) m (SD) m (SD) m (SD) m (SD)
Sociodemographics
Age (years) 20.77 (1.54) 20.94
(2.12)
t206 = 0.518,
p = 0.61
20.75 (1.59) 20.98 (1.63) 20.76
(1.93)
F2,117 = 0.217, p = 0.81
Education (years) 14.51 (1.33) 14.56
(1.49)
t206 = 0.241,
p = 0.81
14.38 (1.39) 14.60 (1.35) 14.52
(1.50)
F2,117 = 0.223, p = 0.80
Females (%) 39% 44% 0.03 (χ2) 56% 33% 58% 0.038
aEstimated Verbal IQ 109.07
(7.26)
110.00
(6.94)
t197 = 0.790,
p = 0.43
108.31
(7.69)
109.33 (5.61) 110.16
(6.65)
F2,110 = 0.692, p = 0.50
Substance Use
Lifetime Cocaine Uses (n) 20.46
(36.99)
N/A 9.03 (15.37) 39.07 (52.50) N/A F2,117 = 17.,347, p = 0.001d
Lifetime Prescription
Stimulant Uses (n)
25.39
(65.40)
N/A 22.38
(28.27)
43.76 (118.00) N/A F2,117 = 4.135, p = 0.263
d
Lifetime Cannabis Uses (n) 900.68
(1417.41)
21.84
(87.06)
t205 = 7.723,
p<0.001
19.25
(15.04)
2466.81
(1908.16)
4.02
(9.47)
F2,117 = 64.556, p = <0.001, High
THC OSU > CS and Low THC
OSU
Number of Drinks in
Preceding Week (n)
14.58
(13.99)
2.16
(4.52)
t193 = 9.368,
p <0.001
11.03
(10.69)
17.54 (15.75) 1.57
(3.79)
F2,111 = 22.101, p = <0.001, High
and Low THC OSU > CS
Typical Number of Weekly
Drinks (n)
19.64
(14.56)
4.80
(3.49)
t190 = 11.382,
p<0.001
16.28
(13.16)
22.39 (14.57) 4.6 (3.59) F2,103 = 23.376, p = <0.001, High
and Low THC OSU > CS
Number of Current Smokers
(n)
65% 6% 28% 64% 2%
Lifetime Ecstasy Uses (n) 2.93 (4.80) 0.02
(0.14)
t205 = 7.588,
p<0.001
1.42 (3.72) 5.33 (6.19) 0.00
(0.00)
F2,116 = 19.097, p = <0.001, High
THC OSU > CS and Low THC
OSU
Traits and Symptoms
b,cNumber of ADHD
Symptoms
1.64 (3.20) 0.94
(1.63)
t134 = 0.896,
p = 0.37
1.34 (2.63) 2.26 (4.25) 2.39
(3.95)
F2,117 = 0.816, p = 0.44
cNumber of Conduct
Symptoms
1.60 (1.66) 0.62
(0.93)
t206 = 3.980,
p<0.001
1.16 (1.53) 2.02 (1.69) 0.54
(0.91)
F2,117 = 12.473, p<0.001, High
THC OSU > CS and Low THC
OSU
Impulsivity (BIS total) 65.41 (9.46) 60.82
(6.70)
t206 = 3.186,
p = 0.002
64.38
(10.19)
66.24 (8.57) 60.33
(6.74)
F2,117 = 5.672, p = 0.004, High
THC OSU > CS
Sensation Seeking (SSS
total)
24.98 (4.62) 19.54
(6.11)
t206 = 5.789,
p<0.001
23.39 (4.38) 25.31 (4.58) 18.67
(5.35)
F2,117 = 21.815, p<0.001, High
and Low THC OSU > CS
Symptoms of Depression
(BDI total)
2.43 (3.12) 1.70
(2.67)
t194 = 1.405,
p = 0.16
2.33 (3.03) 2.80 (3.05) 1.54
(2.66)
F2,107 = 1.914, p = 0.152
Abbreviations: OSU, occasional stimulant users; CS, stimulant naïve comparison subjects; THC, marijuana; Prescription Stimulants = Adderall, Ritalin
(used without prescription); BIS, Barrett impulsiveness scale; SSS, sensation seeking scale, BDI, Beck depression inventory; ADHD, attention deﬁcit
hyperactivity disorder.
a Verbal IQ estimated via WTAR or NAART.
b Maximum number of ADHD symptoms = 21 (n = 10 attention deﬁcit symptoms, n = 11 hyperactivity symptoms).
c ADHD (age 6–13) and conduct (<18 years) symptoms as assessed during in-person clinical interview (SSAGA).
d refers to t-test between Low and High THC OSU.
* Signiﬁcance level of p<0.05.
doi:10.1371/journal.pone.0127010.t001
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Risky Gains Task (RGT)
The exact experimental task (Fig 1) has previously been used in our group [23, 50, 51]. Subjects
were shown the numbers 20, 40 and 80 in ascending order (1s each), representing 20, 40 and
80 cents to be actually added to their total at the end of the experiment (gains of +20, +40, +80
cents). Participants were told that 20 was always the “safe option” but that they had the option
to wait 1 second to receive 40 cents or wait for another second and receive 80 cents. However,
they were told that there was a chance that 40 or 80 might come up in red, representing actual
losses of money from the total to be paid at the end of the study (losses of -40, -80). 40 and 80
were explicitly referred to as “risky options”.
Fig 1. Risky Gains Task. In two subsequent gambles on 96 trials, subjects could gamble the safe option (cash in 20 cents) for double or nothing, to gain 40
or, in the potential second gamble, 80 cents (“risky” decisions). Positive values needed to be collected within their respective 1sec presentation window. 54
trials were predefined as rewarded (+20, +40, +80), 24 as punished 40 trials (-40) and 18 as punished 80 (-80) trials. Overall totals were displayed on top after
a given trial, so that subjects could monitor their performance and monetary wins and losses. Decision phase regressors for fMRI analysis were defined as
lasting from the onset of the trial until the subject had made a response, or, in the case of a response latency greater than 1sec, until the subject was
presented with a negative value. The baseline regressor encompassed the time to initiation of the trial and the time after presenting the outcome, and also
included the null trials that are interspersed.
doi:10.1371/journal.pone.0127010.g001
Risk Processing in Occasional Stimulant Users
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Unbeknownst to subjects, the frequency of a -40 or -80 outcome was predefined such that
their final gain would be identical if they consistently selected 20, 40, or 80 cents. In other
words, there was no inherent advantage of selecting risky over safe choices. Subjects were in-
structed that a positive value needed to be collected (index finger button press) in the respective
1s window. A press thereafter would result in a loss of the presented value. The length of 1s for
this response window was chosen to even allow for potentially slow responding individuals to
collect a desired option. Longer time frames may have encouraged relatively impatient or im-
pulsive subjects to collect a given amount. Wins and losses were accompanied by auditory feed-
back (“yay” for wins and “yuck” for losses respectively). The overall total was displayed on top
after the trial was completed so that subjects could monitor their performance and see the
amount to be paid out in dollar at the end of the study.
The task comprised 96 trials, which lasted 3.5s regardless of subject’s response. Three trial
types were presented in a pre-set randomized order: 54 rewarded trials (+20, +40, +80), and
punished 40 (-40) and punished 80 (-80) trials. Besides potential losses due to subjects’ non- or
slow responding on rewarded trials, the following setup resulted in different amounts of pun-
ished 40 and 80 trials per subject: 24 trials were predefined as punished 40 trials (-40), and 18
trials as punished 80 trials (-80). However, if a subject pressed to collect 20 on a trial meant to
be a -40 trial, or tried to collect 20 or 40 on a dedicated -80 trial, the subject received the collect-
ed amount, therewith reducing the number of punished trials. 22 subjects (17 OSU, 5 CS) did
not respond on one (n = 18 subjects) or more (n = 4 subjects, with a maximum of three missed
responses, Table 2) of the rewarded trials, whereas the 188 remaining subjects responded in
time on all 54 rewarded trials.
Table 2. Behavioral results on the risk taking task by group status.
OSU
(n = 158)
CS
(n = 50)
Low THC OSU
(n = 32)
High THC OSU
(n = 42)
CS
(n = 46)
m (SD) m (SD) t-test results* m (SD) m (SD) m (SD) One-way ANOVA
results*
Decision-making
Safe Decisions
Number of Safe Decisions
(+20)
43.55
(17.44)
43.50
(18.89)
t206 = 0.86,
p = 0.93
48.25 (18.53) 44.62 (18.30) 43.85
(19.55)
F2,117 = 0.556,
p = 0.58
Risky Decisions
% Risky Decisions 50.22
(16.76)
50.00
(18.18)
t206 = 0.80,
p = 0.94
45.78 (17.81) 49.19 (17.50) 49.94
(18.82)
F2,117 = 0.536,
p = 0.59
Number of Rewarded Risky
Trialsa (n)
28.64 (9.98) 28.16
(10.62)
t206 = 0.291,
p = 0.77
25.75 (10.19) 28.19 (10.62) 28.13
(11.04)
F2,117 = 0.598,
p = 0.55
Number of Punished Risky
Trialsb (n)
17.93 (7.07) 18.00
(7.22)
t206 = 0.060,
p = 0.95
16.44 (7.54) 17.79 (7.44) 18.02
(7.48)
F2,117 = 0.456,
p = 0.63
Response To Punishment
% Risky Responses without
prior Punishment
53.04
(18.49)
52.15
(19.66)
t206 = 0.291,
p = 0.77
47.68 (18.87) 52.20 (19.67) 52.09
(20.45)
F2,117 = 0.598,
p = 0.55
% Risky Responses after
Punishment
30.96
(19.30)
29.12
(18.14)
t206 = 0.597,
p = 0.55
27.57 (22.80) 30.32 (17.96) 29.01
(17.67)
F2,117 = 0.185,
p = 0.83
Abbreviations: OSU, occasional stimulant users; CS, stimulant naïve comparison subjects.
a rewarded risky trials refers to +40 and +80 trials.
b Punished risky trials refers to -40 and -80 trials.
* Signiﬁcance level of p<0.05.
doi:10.1371/journal.pone.0127010.t002
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Image Acquisition
The entire scanning session took about 60min and was preceded by a brief training session out-
side the MR scanner. The decision making task was implemented in a randomized fast-event
related design, which was time-locked to the onset of 256 whole brain acquisitions (T2-
weighted EPI on a Signa EXCITE, GE Healthcare, Milwaukee, Wisconsin, 3T scanner;
TR = 2000ms, TE = 32ms, FoV = 230x230 mm2, 64x64 matrix, 30 2.6-mm axial slices, 1.4mm
gap, flip angle = 90°, duration: 8min, 32sec). Six resting trials were interspersed between 96
trials and ignored for analysis. During the same experimental session, a high-resolution
T1-weighted image (TR = 8ms, TE = 3msec, FoV = 250x250 mm2, 192x256 matrix interpolated
to a 256x256 matrix, flip angle = 12°, 172 sagitally acquired slices, .97x.97x1 mm3 voxels) was
obtained for reference.
Data Analysis
Grouping. Following comparisons of our main groups of interest (OSU, CS), effects of co-
use of THC on decision making performance and related brain activation were addressed.
Given that OSU and CS differed on lifetime THC use, it would be inappropriate to include it as
a covariate [52]. Hence, OSU with high THC use (High THC-OSU, reporting>1000 lifetime
uses and fulfilling THC abuse criteria, n = 42) were compared to OSU with low THC co-use
(Low THC-OSU, reporting<50 lifetime uses, n = 32) and CS reporting<50 lifetime THC uses
(n = 46). Comparison of OSU’s and CS’s sociodemographic data, substance use and traits and
symptoms was compared by means of t-tests. Subgroup analyses were carried out in ANOVAs.
Behavioral analysis. The frequency of safe responses (+20) versus risky responses (+40;
-40; +80; -80) as an index of risk-taking behavior was admitted to t-tests. We collapsed across
all risky decisions to allow for a relatively even split between risky and safe decisions. T-tests
were run to compare behavioral performance of OSU and CS, while ANOVAs were drawn on
to compare 32 Low and 46 High THC-OSU with 46 CS reporting fewer than 50 lifetime THC
uses. To analyze responses to monetary losses, the frequency of risky responses was examined
as a function of preceding punishment (-40, -80).
Behavioral regressors for fMRI analysis. Five individual decision making regressors were
constructed, starting from the onset of the trial (presentation of +20) and lasting until the sub-
ject made a response to collect 40 or 80 cents, until -40 or -80 were presented on dedicated
punished trials or, in the case of a response latency greater than one second, until the subject
was presented with a -40 or -80 (see Fig 1). Regressors reflected whether subjects (1) selected
the safe response 20 (+20), (2) held out for 40 and gained 40 cents (+40), (3) held out for an 80
and gained 80 cents (+80), (4) held out for a 40 but lost 40 cents (-40), and (5) held out for 80
but lost 80 cents (-80).
fMRI data analysis. fMRI data were analyzed with AFNI (Analysis of Functional Neuroi-
mages [53]).
Preprocessing. The temporal region with the largest span of fewest voxel-wise outliers was
identified as a base for registration. Time series images were aligned to this base in dx, dy, dz,
roll pitch and yaw directions. These adjustment parameters were used as nuisance regressors to
account for movement. Data points with abnormally large amplitude relative to the surround-
ing time points were eliminated and interpolated. An automated coregistration of EPI and ana-
tomical images was followed by censoring of additional time points exceeding the mean
number of voxel outliers for the series. Additionally, experienced fMRI investigators (M.R., T.
M.F.) inspected data sets for artifacts and sufficiency of alignment. Anatomical images were
talairached by experienced investigators. Images were transformed into Talairach space.
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First level analysis. Multiple regressor analysis and individual linear contrasts were set up in
AFNI’s 3dDeconvolve. Specifically, deconvolution was performed examining the decision
phase (risky decisions, safe decisions), including nuisance motion regressors (roll, pitch and
yaw directions), a baseline (encompassing the time to initiation of the trial and the time after
presenting the outcome; also including the interspersed null trials) and a linear drift regressor.
Images were spatially smoothed applying a Gaussian filter 6mm full-width-half-maximum.
The individual percent signal change (PSC) for risky (+40, -40, +80, -80) and safe (+20) deci-
sions was calculated on a voxel-by-voxel basis throughout the entire brain and was obtained by
dividing the coefficient of the regressor of interest by the baseline regressor.
Second level analysis. A linear mixed effects (LME [54]) analysis was conducted in R (http://
cran.us.r-project.org/). Subjects were treated as random effects; group (OSU, CS) and decision
(risky, safe) as fixed effects. The main effect group and the group by decision interaction served
as the effects of interest to examine risk taking differences between OSU and CS. Whole brain
analyses were performed and, following hypotheses, an additional region of interest (ROI)
analysis was restricted to areas with particular relevance to risk taking, namely the caudate,
insula and ACC. ROIs were defined based on the Talairach atlas [55, 56] and were combined
into one “risk mask” comprising all ROIs. Analysis of fMRI data is usually preformed in a
voxel-wise approach with all statistical tests conducted separately and simultaneously. Afni’s
program AlphaSim [57], a threshold adjustment method based on Monte-Carlo simulations,
was drawn on to guard against identification of false positive areas of activation. Specifically,
AlphaSim takes the 6mm blur (see above) in conjunction with a cluster significance of p<0.05
into consideration. It identified a minimum volume of 1984μL for whole brain analyses to
achieve a corrected p-value of p<0.05, while at least 640μL were required for the insula, 832μL
for the ACC and 448μL for the caudate.
Secondary analyses. Three secondary analyses were conducted. First, the effect of cumula-
tive substance use on brain activation was probed within OSU. Specifically, a Huber robust re-
gression [58] was computed with lifetime use of stimulants and THC as predictors. The
dependent measure was PSC during risky decisions. Lifetime stimulant use was natural log-trans-
formed +1 due to non-normal distributions and was z-scored prior to regression entry. Second,
the effect of lifetime THC co-use on brain activation was analyzed running an LME analogous to
the main analysis: Low and High THC-OSU and CS were compared, focusing on the effects of
group, decision (risky, safe) and the interaction group by decision. Third, a robust regression
probing on risk adjustment-associated brain activation was run performed separately within CS
and OSU. Here, the behavioral responses to punishment (percentage of risky and safe decisions
following monetary loss) were predictors, wherein the dependent variable was PSC during risky
and safe decisions. R2 was calculated on the peak cluster activation and was corrected via Alpha-
Sim via t-values associated with each beta coefficient. A corrected p-value of .05 was applied.
Results
Behavioral Results
OSU and CS did not differ on their percentage of safe and risky responses or on their response
to punishment, as reflected by a relative percentage of safe (+20) and risky (+40, -40, +80, -80)
responses immediately following losses. Moreover, Low and High THC OSU and CS did not
differ behaviorally (Table 2).
Neuroimaging Results
Group main effect. Results (Table 3) indicated that OSU showed attenuated activation in
SFG, middle frontal gyrus (including DLPFC), dorsal striatum, and anterior/posterior insula
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compared to CS during decision making across risky and safe decisions (Fig 2). These findings
were neither explained by use of alcohol, nicotine or THC, nor by self-reported impulsivity or
sensation seeking tendencies as revealed by correlation analyses (S2 Table).
Group by decision interaction. Relative to CS, OSU displayed less activation during risky
decisions in dorsal striatum, amygdala, hippocampus, sgACC and medial frontal gyrus
(Table 4, Fig 3). In comparison, OSU showed greater activation during safe decisions in IFG,
posterior cingulate, superior temporal gyrus and cuneus.
Effect of lifetime stimulant use. After controlling for THC use, OSU who had consumed
relatively more stimulants showed relatively lower dACC (x = 1, y = 16, z = 23, 6080μl; x = 1,
y = 20, z = 18, 3072μl, Fig 4) and posterior insula (x = -33, y = -17, z = 15, 768μl) but more left
anterior insula (x = -44, y = -1, z = 1, 832μl) activation during risky decisions.
Effect of lifetime THC use. Subgroup LME analyses identified brain regions affected by
the amount of THC co-use. High THC-OSU exhibited greater striatum, DLPFC and anterior
insula activation than Low THC-OSU and CS across risky and safe decisions as well as more
parietal recruitment than Low THC-OSU and more posterior cingulate involvement than CS
(Table 5, Fig 5A). Moreover, High THC-OSU presented relatively more striatal, IFG, medial
and middle frontal and superior temporal activation than Low THC-OSU during safe decisions
only (interaction subgroup by decision, Table 6, Fig 5B) leading to a deamplified neural differ-
entiation of risky and safe decisions.
Brain Behavioral Relationships. Table 7 summarizes brain regions associated with risk-
taking as a function of preceding losses as identified in whole brain and risk mask analyses re-
spectively. In CS, individuals who were more likely to respond with selecting a safe option after
monetary loss also had greater activation in dorsal striatum (R2 = 0.14), dACC (R2 = 0.054)
and cuneus (R2 = 0.105) when they selected a safe option. A similar relationship was observed
for OSU in the dorsal striatum (left, R2 = 0.011; right, R2 = 0.016). Moreover, OSU who selected
a safe response relatively more often after losses also had greater activation in dACC (R2 =
0.017) and IFG (R2 = 0.008) when choosing this option. In contrast, OSU who selected risky
options relatively more often after punishment displayed less activation in an area extending
from the dorsal striatum to sgACC (R2 = 0.048), as well as IFG (BA 44, R2 = 0.059) and posteri-
or insula (R2 = 0.038).
Table 3. fMRI linear mixed effects results for the group (OSU, CS) main effect (n = 208).
Region L/R Volume (μl) x y z
1Superior / Middle Frontal Gyrus (including DLPFC; BA 10/46) R 3264 28 51 17
1Middle Occipital Gyrus L 2432 -40 -84 5
1Caudate L/R 2048 -1 13 9
2Caudate L 640 -5 12 7
2Posterior Insula L 1024 -41 -13 2
2Anterior Insula L 640 -39 18 2
For all regions of interest identiﬁed, CS showed stronger activations than OSU. Cluster signiﬁcance of p <
.05 corrected for multiple comparisons (voxel-wise probability: p < .05, F1,156 = 3.89).
Abbreviations: R, right; L, left; x, y and z: Brodmann Area (BA) coordinates; OSU, occasional stimulant
users; CS, stimulant naïve comparison subjects; BA, Brodmann Area; SFG, superior frontal gyrus; DLPFC,
dorsolateral prefrontal cortex.
1 Whole brain analysis.
2 Risk mask analysis.
doi:10.1371/journal.pone.0127010.t003
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Discussion
This study examined whether individuals who put themselves at high risk for stimulant depen-
dence by using stimulants occasionally, show behavioral and/or neural processing differences
in risk-taking decision making situations and yielded three main findings. First, OSU did not
differ from healthy comparison subjects on their preference for risky versus safe options. Sec-
ond, OSU showed attenuation of brain activation in areas that are important for risk processing
as well as reduced neural differentiation of risky and safe options in brain areas essential for
cognitive control mechanisms and bodily representation of risk. Third, THC use did not mod-
ulate these findings, but excessive co-use had additional effects on neural activation, which
could contribute to poorer processing of risk.
Fig 2. Occasional stimulant users (OSU) show an attenuated left anterior insula and right dorsolateral prefrontal (DLPFC) activation during risky
and safe decisionmaking. LME analysis results, group main effect (n = 208). Cluster significance of p < .05 corrected for multiple comparisons (voxel-wise
probability: p < .05). R indicates right; error bars represent standard errors; CS = comparison subjects.
doi:10.1371/journal.pone.0127010.g002
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In line with our hypothesis based on stimulant dependent individuals [39, 45, 59, 60], OSU
exhibited insula and DLPFC attenuation across safe and risky decision making. Moreover,
OSU relative to CS showed lower sgACC and striatal activation during risky decisions, but
smaller IFG deactivation during safe decisions. OSU with greater lifetime stimulant use exhib-
ited lower dACC and posterior insula activation during risky decision making. Finally, higher
amounts of THC co-use were associated with a less pronounced deactivation and less neural
differentiation of risky and safe options within the striatum, insula and prefrontal cortex. OSU
who adjusted behavior towards lowered risk as a response to monetary losses resembled CS
[26, 28, 29, 61] by exhibiting dorsal striatum, IFG, and dACC activation during decision mak-
ing more than OSU who engaged in continued risk. Taken together, these results support the
hypothesis that individuals even at very early stages in their stimulant use show aberrant risk-
related brain activation towards recruiting brain areas less that are important for cognitive con-
trol or interoceptive processing. Attenuated neural differentiation of risky and safe options
may lead an individual to process risky options and/or associated outcomes differently. This
blunted neural response especially in brain areas essential for cognitive control mechanisms
may make it difficult for OSU to refrain from risky decisions.
Given that the present study design was cross-sectional and did not include subjects prior to
any stimulant use in a follow-up design, we cannot strictly conclude that these differences pre-
cede the onset of stimulant use. Nevertheless, because OSU had minimal exposure to stimu-
lants and the majority of brain differences were not affected by THC use, it is most likely that
these differences are not a consequence of extended stimulant use. Taken together, we identi-
fied brain activation patterns in OSU typical for chronic users [38–40, 45, 60, 62, 63] at stages
where subjects–in this case high functioning students in challenging academic situations–and
their environment, e.g. school, work and health care system, may not be aware of this height-
ened risk as overt behavioral impairments are not yet prominent. Given the minimal exposure
Table 4. fMRI linear mixed effects results for the group (OSU, CS) by decision (win risky vs. win safe) interaction (n = 208) .
Region L/
R
Volume
(μl)
x y z Win Risky
Decisions
Win Safe
Decisions
1Medial Frontal Gyrus (BA 6), Precentral/Postcentral Gyri L/
R
17,856 -1 -34 56 CS > OSU ns
1Inferior Frontal Gyrus (BA 44/45), Precentral Gyrus L 2880 -54 6 12 ns OSU > CS
1Middle Temporal Gyrus, Lentiform Nucleus, Putamen, Amygdala,
Hippocampus
L 13,184 -48 -35 -6 CS > OSU ns
1Parahippocampal Gyrus, Thalamus R 7872 24 -49 -6 ns OSU > CS
1Lingual Gyrus L 6656 -16 -45 -4 ns OSU > CS
1Lingual Gyrus L 5952 -5 -85 -8 CS > OSU ns
1Inferior Temporal Gyrus R 6464 51 -12 -20 CS > OSU ns
1Superior Temporal Gyrus R 3136 53 -57 16 ns OSU > CS
1Cuneus L 2432 -4 -71 21 ns OSU > CS
1Posterior Cingulate L 2304 -19 -62 13 ns OSU > CS
2Subgenual ACC (BA 25) R 1024 2 6 -8 CS > OSU ns
Cluster signiﬁcance of p < .05 corrected for multiple comparisons (voxel-wise probability: p < .05, F1,156 = 3.89).
Abbreviations: R, right; L, left; x, y and z: Brodmann Area (BA) coordinates; OSU, occasional stimulant users; CS; stimulant naïve comparison subjects;
BA, Brodmann Area; IFG, inferior frontal gyrus; ACC, anterior cingulate cortex. Within each group, percent signal change for all Win Risky decisions was
greater than Win Safe decisions.
1 Whole brain analysis.
2 Risk mask analysis.
doi:10.1371/journal.pone.0127010.t004
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to neurotoxic substances in our sample, we hypothesize that these may have preceded stimu-
lant initiation. Longitudinal studies starting in stimulant naïve individuals are needed to verify
this hypothesis.
Behaviorally, OSU performed comparably to CS, which is at odds with our prior investiga-
tion using the risky gains task in a small sample of OSU [23]. One possible explanation for this
contradiction is the fact that only students without evidence for ADHD or antisocial personali-
ty disorder were included into the current investigation. The absence of behavioral differences
is in line with our previous findings of absent or only subtle cognitive impairments on standard
neuropsychological tests [64, 65] and other neuroimaging tasks [66, 67] in this sample. The
Fig 3. Occasional stimulant users (OSU) present lower subgenual anterior cingulate cortex (sgACC) recruitment during risky decisions and less
deactivation of inferior frontal gyrus to safe decisions than comparison subjects (CS). LME analysis results, group by decision (risky vs. safe)
interaction (n = 208). Cluster significance of p < .05 corrected for multiple comparisons (voxel-wise probability: p < .05). R indicates right, error bars represent
standard errors, asterisk = sign. at p = 0.05.
doi:10.1371/journal.pone.0127010.g003
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absence of behavioral alterations at early stages of stimulant use suggests that cognitive impair-
ments may increase with greater use of drugs [22, 68] as research has highlighted behavioral
impairments in chronic users. Nevertheless, neural differences emerged between OSU and CS
despite the absence of behavioral impairments in OSU, suggesting that OSU and CS differ in
the process arriving at decisions. Specifically, OSU presented an attenuated neural differentia-
tion of risky and safe decisions, thus seemed less sensitive to adverse consequences of risk tak-
ing. This finding extends recent results of our group showing a blunted neural response to risk
in the absence of performance differences to be indicative of relapse to stimulant use [50].
OSU displayed a pronounced attenuation of dorsal striatum, ACC, prefrontal and insular
activation to both risky and safe decisions. Drawing on findings in healthy subjects and stimu-
lant dependence [26, 27, 36, 37, 44, 69], these results suggest that neural decision making
Fig 4. Huber robust regression with lifetime substance use in occasional stimulant users (n = 158). Stimulant users with relatively greater lifetime
stimulant uses show a diminished recruitment of anterior cingulate. Risky vs. safe decisions, cluster significance of p < .05 corrected for multiple comparisons
(voxel-wise probability: p < .05).
doi:10.1371/journal.pone.0127010.g004
Table 5. fMRI linear mixed effects results for the group (low THC-OSU, high THC-OSU, low THC-CS)
main effect (n = 120).
Region L/R Volume (μl) x y z
High THC OSU showing stronger activation than CS and Low THC OSU
Lentiform Nucleus, Putamen R 3776 24 10 -3
Middle Frontal Gyrus (incl. DLPFC), Precentral Gyrus R 2496 44 24 36
Anterior Insula R 2048 39 20 13
High THC OSU showing stronger activation than Low THC OSU
Cuneus R 3328 2 -82 14
Inferior Parietal Lobule L 2048 -50 -27 24
High THC OSU showing stronger activation than CS
Posterior Cingulate L 1984 -15 -53 11
Whole brain analysis results. Cluster signiﬁcance of p < .05 corrected for multiple comparisons (voxel-wise
probability: p < .05, F2,117 = 3.07).
Abbreviations: R, right; L, left; x, y and z: Brodmann Area (BA) coordinates.
doi:10.1371/journal.pone.0127010.t005
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impairments in OSU relate to dysfunctions in all aspects of decision making. First, OSU
showed attenuated recruitment of prefrontal cortex, ACC, ventral striatum and left anterior
insula. These areas are, among others, crucial for various cognitive rather than motivational/
emotional aspects of decision making, e.g. discerning reward values of available choices, main-
taining task objectives in short term memory, calculation of risk prediction error or choice-out-
come contingency learning. Thus, these findings are similar to findings observed in stimulant
dependent subjects. Specifically, chronic cocaine and methamphetamine dependent patients in
contrast to non-users have for instance been shown to exhibit DLPFC and SFG hypoactivation
for instance during delay discounting tasks, which require subjects to weigh alternatives with
immediate or short-term outcomes against decisions with higher, but delayed pay offs while
making decisions during hard compared to easy trials [39, 62] as well as DLPFC reductions
Fig 5. Effects of co-use of marijuana.Occasional stimulant users with relatively high numbers of lifetime co-use of marijuana (High THC OSU) are
characterized by (A) a weaker relative deactivation of the right anterior insula to risky and safe decisions (main effect of subgroup,) and (B) a weaker neural
differentiation of risky and safe decisions in the dorsal striatum compared to Low THC OSU driven by an absent relative decrease of activation during safe
decisions (interaction subgroup by decision), n = 120. Cluster significance of p < .05 corrected for multiple comparisons (voxel-wise probability: p < .05). R
indicates right, error bars represent standard errors, asterisk = sign. at p = 0.05.
doi:10.1371/journal.pone.0127010.g005
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during decision making [45, 60]. Prior work also demonstrates IFG reductions in stimulant de-
pendent individuals during decision making [40–43]. Our findings now suggest that decision
making related attenuation of prefrontal recruitment is prominent at very early stages of stimu-
lant use, suggestive of a neural pattern potentially promoting initiation of stimulant use.
Second, OSU were also characterized by attenuated activation of the dACC, a brain area
crucial for detection of conflict and action selection. Moreover, OSU presented attenuated
rACC and sgACC activation, which have been related to motivational and learning-related as-
pects of goal-directed behavior [32–34]. Our findings in OSU extend prior work in chronic
users, where cocaine dependent patients showed reduced ACC activation across risky and safe
conditions while gambling [38]. Multi-substance abusers also exhibited attenuated ACC activa-
tion, which correlated with a greater number of risky decisions [19]. Third, attenuation of stria-
tal, sgACC and insula activation support the notion that OSU experience risk as less aversive
than CS as revealed by research on non-users with different risk preferences [70]. The attenua-
tion also suggests a diminished linkage of risk with positive and negative outcomes in OSU.
Risk-outcome associations, however, are essential for successful behavioral adjustment in
terms of subsequent avoidance of punishment. Prior work in chronic substance users revealed
diminished caudate activation to a variety of non-drug rewards [46, 47], findings summarized
as the ‘reward deficiency syndrome’ hypothesis. Our findings of attenuated insula activation in
a substantial sample of OSU are in line with previous decision making studies in cocaine de-
pendent patients [40], relapsing methamphetamine dependent individuals [63], and OSU [71],
whereas multi-substance abusers showed greater insula activation to higher number of risky
choices [19]. Together, these patterns of neural attenuation in OSU in brain regions required
for successful goal-directed decision making and generation of an interoceptive awareness to
generate internal alarm signals to avoid risk may in the end promote continued risk-taking like
drug use.
Secondary analyses verified that THC, which was substantially consumed by some of our
participants, did not directly influence these activation patterns. While THC is known to
Table 6. fMRI linear mixed effects results for the group (low THC-OSU, high THC-OSU, low THC-CS) by decision (win risky vs. win safe) interaction
(n = 120).
Region L/R Volume (μl) x y z Win Safe Decisions
1Parahippocampal Gyrus, Superior Temporal Gyrus L 4224 -25 -22 -17 High THC OSU > Low THC OSU
1Superior Temporal Gyrus R 4224 47 -58 28
1Middle Temporal Gyrus L 3904 -47 5 -25
1Superior, Middle, and Inferior Temporal Gyrus R 2112 44 1 -30
1Lentiform Nucleus, Globus Pallidus, Thalamus R 3648 24 -18 -4 High THC OSU > Low THC OSU
1Declive R 4224 1 -78 -12
1Postcentral Gyrus L 3968 -27 -32 58
1Paracentral Lobule L 2176 -1 -25 51
1Subcallosal Gyrus R 2176 27 4 -10 High THC OSU > Low THC OSU
1Inferior Frontal Gyrus R 2176 43 24 -7 High THC OSU > Low THC OSU
1Medial Frontal Gyrus L/R 1984 -2 45 27 High THC OSU > Low THC OSU
1Middle Frontal Gyrus R 1984 18 4 59 High THC OSU > Low THC OSU
Cluster signiﬁcance of p < .05 corrected for multiple comparisons (voxel-wise probability: p < .05, F2,117 = 3.07).
Abbreviations: R, right; L, left; x, y and z: Brodmann Area (BA) coordinates; ACC, anterior cingulate cortex; SFG, superior frontal gyrus; negative, negative
correlation between lifetime use and BOLD; positive, positive correlation between lifetime use and BOLD.
1 Whole brain analysis.
doi:10.1371/journal.pone.0127010.t006
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promote cognitive and neural impairments [72–74], co-use of THC was not an exclusion crite-
rion, as research shows that more than half of stimulant using students consume THC [4]. The
onset of THC use in our sample typically preceded stimulant initiation. THC had additive neu-
ral effects, in that OSU with heavy THC use were characterized by a lacking differentiation of
risky and safe options in related brain areas critical for decision making (e.g. right anterior
insula and DLPFC), supporting studies revealing dose-dependent THC effects on decision
making and brain activation [18].
Importantly, higher lifetime stimulant use was associated with diminished risk-taking acti-
vation in dACC and posterior insula after controlling for THC co-use. Our dACC findings
demonstrate that OSU with relatively more uses show more pronounced neural decision
Table 7. Huber robust regressions with behavioral responses (% of risky and safe decisions) after punishment predicting brain activation during
risky and safe decision making. In CS, no clusters survived the threshold for prediction PSC during risk taking based on% risky decisions
after punishment.
Group Region L/R Volume (μl) x y z Direction
% Risky Responses After Punishment Predicting PSC for Risky Decisions
OSU* 1Lentiform Nucleus, Caudate, Subgenual ACC (BA 24) L 2752 -9 3 -8 negative
1IFG (BA 44) R 2176 -48 6 20 negative
1Fusiform Gyrus L 21,312 41 -49 -5 negative
1Precentral Gyrus L 10,368 -47 -21 34 negative
1Middle Temporal Gyrus L 7872 -49 -62 3 negative
1Declive L 5184 -46 -52 -19 negative
1Cuneus L 5184 -9 -80 18 negative
1Culmen R 4608 0 -60 4 negative
1Thalamus R 3648 5 -12 6 negative
1Dorsal ACC (BA 24) L 2816 4 -8 32 negative
1Precuneus R 2204 -2 -59 62 negative
2Posterior Insula L 704 41 -17 3 negative
2Caudate R 576 -9 14 -4 negative
2Caudate L/R 512 6 7 6 negative
% Safe Responses After Punishment Predicting PSC for Safe Decisions
CS** 1Caudate/Middle Temporal Gyrus/ Hippocampus/Parahippocampus R 4224 32 -43 6 positive
1Dorsal ACC/Middle Frontal Gyrus R 3648 21 1 38 positive
1Cuneus R 3200 4 -78 21 positive
OSU* 1Precentral/Postcentral Gyrus L 11,136 -35 -25 49 positive
1Cuneus L 2432 -5 -80 12 positive
1Parahippocampal Gyrus L 2112 -7 -38 3 positive
1IFG/Middle Frontal Gyrus (BA 9) R 2112 49 18 26 positive
1Dorsal ACC (BA 24) L/R 1984 2 2 31 positive
2Caudate L 768 -6 14 -2 positive
2Caudate R 640 8 5 8 positive
Cluster signiﬁcance of p < .05 corrected for multiple comparisons (voxel-wise probability: p < .05, critical t-value: 1.98, *df = 1, 157, **df = 1, 49).
Abbreviations: R, right; L, left; x, y and z: Brodmann Area (BA) coordinates; OSU, occasional stimulant users; CS; stimulant naïve comparison subjects;
ACC, anterior cingulate cortex; IFG, inferior frontal gyrus; SFG, superior frontal gyrus; DLPFC, dorsolateral prefrontal cortex; negative, negative correlation
between response to punishment and BOLD; positive, positive correlation between response to punishment and BOLD; PSC, percent signal change.
1 Whole brain analysis.
2 Risk mask analysis.
doi:10.1371/journal.pone.0127010.t007
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making alterations in areas associated with cognitive control functions like response selection,
proactive performance monitoring and conflict monitoring [30], findings consistent with re-
search in chronic users [75–77]. The posterior insula has been shown to play a crucial role in
the generation of interoceptive awareness [36]. The present finding of reduced activation in
those OSU with higher lifetime uses may thus reflect diminished bodily representations of risk.
The perception of (external and) internal alarm signals is crucial for the avoidance of risky be-
havior. While we cannot ultimately differentiate whether OSU with initially more pronounced
brain functional alterations consumed more stimulants in a self-medication approach or
whether repeated exposure to neurotoxic substances resulted in changes in neural activation
patterns, dose-dependency and self-medication hypotheses find support in previous research
showing that more frequent cocaine use leads to more pronounced dACC hypoactivations [78]
whereas acute administration of cocaine fosters normalization of ACC hypoactivity [79]. To
summarize, our dose-related findings suggest that both an attenuation of cognitive control
mechanisms and bodily awareness foster prolonged exposure to risk as neither cognitive nor
internal alarm signals support inhibition of prepotent responses.
Our results focusing on performance following losses revealed that OSU who took lower
risks after monetary losses were characterized by a successful recruitment of brain structures
CS employ to monitor conflict (dACC) and link outcomes with choices (dorsal striatum). On
the contrary, OSU who repeatedly engaged in risk by selecting risky options showed a dimin-
ished activation of the sgACC, which is crucial for motivational aspects of decision making.
OSU also presented alterations of dorsal striatum activation. With the dorsal striatum being
engaged in mechanisms avoiding choices associated with losses, the findings suggest an attenu-
ated emotional representation of risk, which may make it difficult for stimulant users to avoid
risky choices. They may expose themselves to continued risk (e.g. in terms of continued sub-
stance use), which in the end might lead to a higher likelihood to transition to dependence.
Cognitive-behavioral, pharmacological and/or neurofunctional trainings aimed at enhancing
activation in those target areas might enable individuals to re-gain control over risk taking.
In summary, findings demonstrate that individuals at very early stages of stimulant use,
similar to stimulant dependent individuals, show attenuated neural processing of risk and par-
ticularly less pronounced neural differentiation of risky and safe options. Given minimal expo-
sure to stimulants in our sample, these deficiencies may have preceded stimulant initiation and
might serve as vulnerability markers to allow for early intervention. While not directly linked,
neural deficiencies were potentially promoted by THC use as particularly excessive THC users
showed attenuated neural differentiation of risky and safe options in related but distinct net-
works. Through this mechanism, early THC use may have lowered the threshold for stimulant
initiation. Stimulant use was associated with aberrant activation in brain areas crucial for cog-
nitive and motivational aspects of goal-directed decision making. In conjunction with dimin-
ished bodily representations of risk weakening internal warning signals, these characteristics
might foster continued risk-taking and thus increase likelihood for prolonged consumption
and transition to dependence. Critical next steps will be the concrete delineation of risk factors
for the stimulant-using individual and longitudinal studies preferably starting with individuals
prior to any substance use. Such studies might confirm the hypothesized scenario of neural ac-
tivation patterns encouraging continued substance use.
This study has some limitations. First, our study design was cross-sectional and not
completely prospective; we included stimulant using individuals with very limited exposure to
stimulants lacking clinically significant stimulant-related problems. This design makes it diffi-
cult to differentiate between pre-existing characteristics and effects of repeated exposure to
drugs. Nevertheless, the mean number of stimulant exposure was minimal, making neurotoxic
effects of stimulants less likely while supporting the hypothesis of a neural vulnerability
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predisposing to stimulant initiation. Research in stimulant naïve subjects at high risk for stimu-
lant use (e.g. young first degree relatives of stimulant dependent individuals) may separate a ge-
netic vulnerability for stimulant related problems from factors associated with occasional use.
Second, co-use of THC did not serve as an exclusion criterion to allow for a representative sam-
ple of stimulant using young individuals [4]. While the current design did not include a sub-
group of non-stimulant using THC users, we approached a potential THC effect by split group
analyses and revealed that THC did not directly influence effects. THC had additive neural ef-
fects attenuating neural differentiation of risky and safe responses. Longitudinal studies includ-
ing individuals prior to any substance use and the comparison with pure THC users are
warranted to tease apart effects of THC and stimulants. We specifically excluded stimulant
using and comparison subjects with a lifetime history (diagnosis or treatment) of ADHD and
conduct disorder, both of which known to contribute to the propensity of substance use [80].
These strict exclusion criteria may also explain why we could not replicate previous findings of
Leland and Paulus [23] administering the very same task to a smaller sample of OSU. Taken to-
gether, we feel confident that our results of attenuated neural representation of risk-related de-
cision making in OSU delineate precursors of stimulant use problems. Future analyses will
focus on the concrete predictive value for the stimulant-using individual. Third, the task was
set up in a way that there was no inherent advantage of selecting safe or risky options to lead to
similar monetary wins across subjects. While participants were instructed that holding out for
40 or 80 were “risky options”, this implementation did not encourage contingency learning, as
no underlying optimal strategy was reinforced. Lastly, it needs to be discussed whether prede-
termined temporal aspects of our task may have influenced results. In this regard, it is impor-
tant to point out that potential differences in individual response times are unlikely to have
affected our results. The time window during which subjects needed to collect a value displayed
on the screen was set to 1s, so that potentially slow responding subjects were able to collect a
given amount. On the other hand, this window of opportunity (see [23] for a more detailed dis-
cussion) added a certain time pressure to our task, so that waiting was disadvantageous. One
might also argue that our behavioral options not only differed on risk domain but also on wait-
ing domain, as subjects always had to wait longer to gain higher rewards, which increased the
chances of higher losses. Hence, results could technically also be driven by differences in sub-
jects’ willingness to wait, particularly given that OSU and CS differed on some self-reported
measures of impulsiveness. Our results (see S1 Table) however verify, that group differences of
brain activation were not explained by differences in self-reported impulsivity. In addition, our
task was set up in a way that longer waiting would have resulted in monetary losses. Groups
did not differ on the number of missed trials so that we are confident, that our results are not
related to a differential willingness to wait.
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